APA (7th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health & ProQuest (Firm). (2008). Assessing the impact of a safe and equitable biosimilar policy in the United States: Hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007. U.S. G.P.O..

Chicago Style (17th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and ProQuest (Firm). Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States: Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, First Session, May 2, 2007. Washington: U.S. G.P.O., 2008.

MLA (9th ed.) Citation

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and ProQuest (Firm). Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States: Hearing Before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, First Session, May 2, 2007. U.S. G.P.O., 2008.